Deviations from written production and process control procedures are not recorded and justified.
See every finding in this document View the regulator's official sourceBy Country
Sweden manufacturing-site findings
at manufacturing sites in this country 36 findings drawn from 6 published documents. The most recent cases are below; the full set is in search.
See all Sweden findingsWhich agency cited it
Companies with the most findings
Recent findings
Written procedures are not established and followed that describe the in-process controls to be conducted on appropriate samples of in-process materials of each batch.
See every finding in this document View the regulator's official sourceEquipment and(b) (4) are not maintained at appropriate intervals to prevent that would alter the safety, identity, strength, quality or purity of the drug product.
See every finding in this document View the regulator's official sourceThere is a failure to thoroughly review any unexplained discrepancy whether or not the batch has been already distributed.
View the regulator's official sourceThe responsibilities and procedures applicable to the quality control unit are not fully followed.
View the regulator's official sourceYour firm’s cleaning and disinfection program is inadequate to decontaminate a@ ©) @) in drug substance and drug product manufacturing facilities and to address the risk of microbial contamination in controlled manufacturing environments.
See every finding in this document View the regulator's official sourceOther countries
A record as of publication. Check the agency's own announcements for any later corrective action. Counts as of 2026-11-14.